Displacement of epithelium is common after needling procedures, including percutaneous core needle biopsy that is commonly used for evaluation [8] [9] [10] [11] of suspected breast lesions. It occurs in any type of 12 breast lesion. In one study, 22 out of 64 excised breast specimens showed displaced neoplastic cells 13 in needle tracks. In a recent systematic review, displacement rate in a total of 927 cases from nine studies on surgically excised breast specimens 13, 14 ranged from 2% to 63%. This wide range can be attributed to the type of breast lesion (more common in papillary lesions), time interval between needling and surgery, type of procedure, and needle gauge. Although both patients and clinicians may be concerned about the proliferation of displaced malignant cell resulting in tumor recurrence at needling site or distant organs, the risk of this so- [15] [16] [17] [18] called "seeding" is only 0.2% to 0.7%.
Epithelial displacement is important from two points of view including correct histopathologic diagnosis and hazard of needle track seeding or even
Introduction
In breast tissue, displacement of epithelial component, both benign and malignant, may result in a misdiagnosis of invasive carcinoma or metastasis. Therefore, pathologists and other practitioners in the field of breast diseases should be cognizant of this phenomenon. The number and volume of identified tumor cells in needle track is inversely related to the intervening time between core needle biopsy and excision of the 22 lesion. Two main determinants of neoplastic cell displacement along needle tracks are the short term
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Factors influencing the frequency of DE
Having a very low rate of false negative results, VABB has a sensitivity and specificity superior to 23, [39] [40] [41] core needle biopsy.
In three studies, no malignant cell displacement was identified after this procedure. In these studies, 28, 23, and 21 VABBs were performed using 11-G, 14-G, and 11-G needles, 31, 42, 43 respectively.
Procedures resulting in DE
Any type of instrumentation can result in DE, including fine needle aspiration, core needle biopsy, wire localization of lesions, vacuum-assisted breast biopsy (VABB), injections for sentinel lymph node 22, 37 identification, and incisional or excisional biopsies. DE has also been reported after liposuction in a male 35 patient with gynecomastia.
The least damaging method is fine needle aspiration, where a 22-G needle is employed for entering the tumor. Needles with a larger gauge, such as 11-or 14-G, used for tissue diagnosis, result in 38 more frequent DE.
Methods
We searched PubMed for English-language publications related to human subjects using the following keywords: "needle track," "needle tract," "displaced epithelium," "epithelial displacement," and "iatrogenic displacement," which yielded 439 records. We read all the abstracts and selected 27 1, 2, 5-7, 12, 13, 15, 17, [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] papers with the most relevance.
The full texts of the selected papers were obtained. We used both the selected papers and our experience to write the narrative review. The images are all taken from our cases in the Cancer Institute of Tehran University of Medical Sciences.
When the epithelium is dislocated mechanically by surgical or radiological interventions, it is called displaced epithelium (DE). This iatrogenic phenomenon should be distinguished from local invasion or metastasis. In the latter situations, the neoplastic cells that have gained the ability to invade the stroma or vascular channels are dislodged from the main bulk of in situ carcinoma without requiring any external mechanical force. In both situations, some atypical cells are evident in the stroma, regional lymph nodes, or even distant sites such as bone marrow. Therefore, distinguishing between these two entities may be a great challenge for the histopathologist.
Results
Definition of displaced epithelium and how it differs from real invasion or metastasis
between core needle biopsy and excisional surgery 38 and the histology of the tumor.
In benign and malignant papillary lesions, epithelial displacement occurs more commonly in comparison with other neoplasms of the breast because of the fragility of these lesions. In one study in 2005, 50 out of 53 cases with epithelial 27 displacement had an underlying papillary lesion. These epithelia were dislocated to the stroma surrounding the papillary lesions and adjacent lymph-vascular channels imitating invasion. These displaced epithelia can be even transferred to axillary lymph nodes. DE should be suspected when we observe a major intraductal component (particularly if this component is a papillary proliferation) or a small presumably 27 invasive tumor. The surgeon or radiologist should notify the pathologists, if there has been any history of prior biopsy or other instrumentations.
How can DE be differentiated from genuine invasive carcinoma? Apart from being located along needle track with aforementioned histopathologic features, the following characteristics may be helpful:
Histopathologic features of DE and how it can be distinguished from authentic invasion or metastasis
•The displaced cells show some degree of degeneration. It depends on the time interval between needling and excision. The longer this interval is, the more degenerative changes are
• The displaced epithelial cells are usually arranged in a linear pattern ( Figure 5 ).
•Immunostaining for cytokeratin (Figures 7 and  8 ) and CD68 may be helpful in distinguishing between DE and epithelioid histiocytes (Figures  3 and 6) .
identified. changes. The degenerated cells have pyknotic nuclei with increased intensity of cytoplasmic eosinophilia (Figure 6 ). If the interval between needling and biopsy is long enough, the displaced cells become necrotic or are completely removed by macrophages.
•The cells are morphologically similar to the intraductal component.
•Immunostaining for myoepithelial markers and high-molecular weight cytokeratin may be utilized when the intraductal component is a b e n i g n p r o l i f e r a t i o n w i t h p r e s e r v e d 46 myoepithelial cells. However, the absence of staining for these markers does not preclude the •Some displaced epithelial cells may show squamous metaplasia, resulting in its being mistaken as adenosquamous cell carcinoma. possibility of DE.
•Sometimes the displaced epithelia are seen in lymphatic channels. There are even reports about the transfer of the displaced epithelia to the 28, 33, 34, lymph nodes along the lymphatic channels. 36, 37, 47, 48 •Fibrosis related to needling, and not a desmoplastic reaction around invasive carcinoma, is very extensive. Therefore, the displaced epithelia usually constitute a small fraction of an extensive reaction (Figure 3) . Displacement of the epithelium to regional lymph nodes and even remote organs such as bone marrow 37, 49 is on record.
Since most of these cases are misdiagnosed as metastasis by pathologists, the exact frequency of these findings cannot be determined. Some features useful for distinguishing between DE and real metastasis include:
• They are usually evenly distributed in the lymph node sinus and do not form expansile masses or nodules.
• The grade of tumor and its type are less compatible with metastasis, e.g., a low-grade tumor or a papillary or mucinous carcinoma (in these situations, the likelihood of lymph node metastasis is very low, and if we see epithelial cells in lymph nodes, it should be interpreted cautiously).
•DE is evident in lymphatic channels of the breast tissue.
• The displaced cells are usually in the form of isolated cells or small clusters.
• The invasive component is very small (for instance, when we have a microinvasive carcinoma).
• The biomarker results (ER, PR, and HER2) are different from the primary tumor.
• They are accompanied by red blood cells, macrophages, and giant cells.
• The tumor is morphologically different from the invasive carcinoma. Displacement of epithelium often occurs after needle biopsy of a breast lesion. Any epithelial cell can be displaced, including benign intraductal proliferations, in situ carcinoma, and invasive 10 carcinoma. The major diagnostic problem is related to the displacement of intraductal proliferative cells (both benign and malignant) to the stroma or lymphatic channels, which results in misdiagnosis as 8 an infiltrating tumor. Displacement of an invasive carcinoma along the needle track usually poses no diagnostic problem for the histopathologist. Its clinical significance has been discussed elsewhere in the manuscript. Occasionally, the displaced epithelium, dislodged into the lymph-vascular channels, may be carried to the regional lymph node, resulting in detection of isolated tumor cells in 36, 37, 47 sentinel lymph nodes.
Discussion
Diagnosis of DE may be a great challenge for pathologists. Sometimes, it is overcalled as invasive carcinoma.
During diagnostic procedures such as core needle biopsy or aspiration and excisional biopsy, tumor cells can be dislodged and displaced in needle track. Detached tumor cells can also enter lymphatic channels via these procedures and, at least theoretically, According to previous studies, the incidence of tumor seeding and recurrence at the site of needle track is low relative to the frequency of displaced tumor 50 cells at this site. This finding may be explained based on cancer stem cell theory and the characteristics of malignant tumors. All tumors have two basic components including parenchyma and stroma. The stroma is host-derived and crucial for the growth of neoplasms because it supplies blood and essential factors. In tumors, normal interactions between cells and extracellular matrix are altered and disrupted so that tumor cells can detach from each other easily. Tumor cells, as well as host-derived stromal cells, can secrete proteolytic enzymes that can degrade interstitial connective tissue, facilitating the movement 51 of and, eventually, local invasion by tumor cells. Almost all tumors, even at early phases, release cancer cells into blood, but a clinically evident metastatic disease occurs after a long period of latency. This observation suggests that metastatic colonization is an inefficient process and that most cancer cells die in blood. The investigations that show circulating tumor cells outnumber the overt 56 metastatic lesion support this observation.
Disseminated tumor cells need both stem cells and specialized microenvironment to survive. Experimental studies have provided evidence that signals from primary tumor can result in the development of a microenvironment in a distant homing organ. Thus, the so-called "premetastatic niche" is provided before the arrival of circulating tumor cells.
Alternatively, according to cancer stem cell theory, all tumors contain a population of cells that show biologic properties similar to those of normal adult stem cells. These stem cells are responsible, if 53, 54 not crucial, for maintenance of malignant tumors. Moreover, like normal stem cells, they require a specialized microenvironment named "stem cell niche" for regulation and progression of their growth. It represents a dynamic compartment by means of which additional components including endothelial, immune, and stromal cells as well as soluble factors help develop the environment necessary for both self-renewal and differentiation of 52, 55 stem cells.
The low frequency of needle track seeding or metastasis can be due to the absence of cancer stem cells or appropriate microenvironment in the new location. However, this proposal should be confirmed by further investigations. 37, 49 colonize other sites far from the main lesion. How can the low rate of local recurrence at biopsy site or lymph node metastasis be explained despite the presence of tumor cells in lymph nodes?
Cancer cells do not survive alone but recruit normal host-derived cells to serve as contributing members by producing tumor microenvironment. Tissue microenvironment is necessary for the growth of the tumor and also the development of other characteristics of malignancy such as invasion and metastasis. The cells that contribute to the production of tumor microenvironment are cancerassociated fibroblasts, angiogenic vascular cells, and 52 infiltrating immune cells.
Although the frequency of seeding in needle track 26, 29, 57 is very low, it is a well-documented entity.
The risk factors for the development of seeding in the track of breast needling were evaluated in a study by 18 Santiago et al. They showed that the major risk factors included grade 3 infiltrating ductal carcinomas, triple-negative carcinomas, use of noncoaxial needles, and multiple insertions. The frequency of seeding in this study was less than 0.2% (8 of 4010 core needle biopsies) and the mean time between core needle biopsy and development of seeding was 60.8 days.
Undoubtedly, a large number of cases of displaced epithelia are signed out as invasive carcinoma or metastasis by pathologists all over the world. Accordingly, the unexpectedly good prognosis in some cases of presumed invasive carcinoma with regional lymph node metastasis can be attributable to 33, 58, 59 the overcalling of a noninvasive lesion.
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